128 related articles for article (PubMed ID: 38271919)
1. Strengths and challenges in current lung cancer care: Timeliness and diagnostic procedures in six Dutch hospitals.
Genet SAAM; Visser E; Youssef-El Soud M; Belderbos HNA; Stege G; de Saegher MEA; Westeinde SCV'; Brunsveld L; Broeren MAC; van de Kerkhof D; Eduati F; van den Borne BEEM; Scharnhorst V
Lung Cancer; 2024 Mar; 189():107477. PubMed ID: 38271919
[TBL] [Abstract][Full Text] [Related]
2. Liquid biopsy-based decision support algorithms for diagnosis and subtyping of lung cancer.
Visser E; Genet SAAM; de Kock RPPA; van den Borne BEEM; Youssef-El Soud M; Belderbos HNA; Stege G; de Saegher MEA; van 't Westeinde SC; Brunsveld L; Broeren MAC; van de Kerkhof D; Deiman BALM; Eduati F; Scharnhorst V
Lung Cancer; 2023 Apr; 178():28-36. PubMed ID: 36773458
[TBL] [Abstract][Full Text] [Related]
3. Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer.
Huang L; Feng Y; Xie T; Zhu H; Tang L; Shi Y
BMC Cancer; 2023 Apr; 23(1):312. PubMed ID: 37020179
[TBL] [Abstract][Full Text] [Related]
4. Timeliness of lung cancer care in Victoria: a retrospective cohort study.
Evans SM; Earnest A; Bower W; Senthuren M; McLaughlin P; Stirling R
Med J Aust; 2016 Feb; 204(2):75. PubMed ID: 26821108
[TBL] [Abstract][Full Text] [Related]
5. Invasive Diagnostic Procedures from Bronchoscopy to Surgical Biopsy-Optimization of Non-Small Cell Lung Cancer Samples for Molecular Testing.
Lalić N; Lovrenski A; Ilić M; Ivanov O; Bojović M; Lalić I; Popević S; Stjepanović M; Janjić N
Medicina (Kaunas); 2023 Sep; 59(10):. PubMed ID: 37893442
[No Abstract] [Full Text] [Related]
6. Care of patients with non-small-cell lung cancer stage III - the Central European real-world experience.
Zemanova M; Pirker R; Petruzelka L; Zbozínkova Z; Jovanovic D; Rajer M; Bogos K; Purkalne G; Ceriman V; Chaudhary S; Richter I; Kufa J; Jakubikova L; Zemaitis M; Cernovska M; Koubkova L; Vilasova Z; Dieckmann K; Farkas A; Spasic J; Fröhlich K; Tiefenbacher A; Hollosi V; Kultan J; Kolarová I; Votruba J
Radiol Oncol; 2020 May; 54(2):209-220. PubMed ID: 32463394
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with treatment receipt and overall survival for patients with locally advanced large cell neuroendocrine carcinoma of the lung: A National Cancer Database analysis.
Limonnik V; Abel S; Finley GG; Long GS; Wegner RE
Lung Cancer; 2020 Dec; 150():107-113. PubMed ID: 33126090
[TBL] [Abstract][Full Text] [Related]
8. Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study.
Kinslow CJ; May MS; Saqi A; Shu CA; Chaudhary KR; Wang TJC; Cheng SK
Clin Lung Cancer; 2020 Mar; 21(2):e99-e113. PubMed ID: 31601526
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with timeliness of post-primary care referral, diagnosis and treatment for lung cancer: population-based, data-linkage study.
Forrest LF; Adams J; White M; Rubin G
Br J Cancer; 2014 Oct; 111(9):1843-51. PubMed ID: 25203519
[TBL] [Abstract][Full Text] [Related]
10. Does timeliness of care in Non-Small Cell Lung Cancer impact on survival?
Vinod SK; Chandra A; Berthelsen A; Descallar J
Lung Cancer; 2017 Oct; 112():16-24. PubMed ID: 29191589
[TBL] [Abstract][Full Text] [Related]
11. Transfer between hospitals as a predictor of delay in diagnosis and treatment of patients with Non-Small Cell Lung Cancer - a register based cohort-study.
Iachina M; Jakobsen E; Fallesen AK; Green A
BMC Health Serv Res; 2017 Apr; 17(1):267. PubMed ID: 28403839
[TBL] [Abstract][Full Text] [Related]
12. The effect of a lung cancer care coordination program on timeliness of care.
Alsamarai S; Yao X; Cain HC; Chang BW; Chao HH; Connery DM; Deng Y; Garla VN; Hunnibell LS; Kim AW; Obando JA; Taylor C; Tellides G; Rose MG
Clin Lung Cancer; 2013 Sep; 14(5):527-34. PubMed ID: 23827516
[TBL] [Abstract][Full Text] [Related]
13. Large-cell neuroendocrine carcinoma of the lung.
Fernandez FG; Battafarano RJ
Cancer Control; 2006 Oct; 13(4):270-5. PubMed ID: 17075564
[TBL] [Abstract][Full Text] [Related]
14. Differences in practice patterns and costs between small cell and non-small cell lung cancer patients in Japan.
Kuwabara K; Matsuda S; Fushimi K; Anan M; Ishikawa KB; Horiguchi H; Hayashida K; Fujimori K
Tohoku J Exp Med; 2009 Jan; 217(1):29-35. PubMed ID: 19155605
[TBL] [Abstract][Full Text] [Related]
15. Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands.
Wouters MW; Siesling S; Jansen-Landheer ML; Elferink MA; Belderbos J; Coebergh JW; Schramel FM
Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S83-92. PubMed ID: 20598845
[TBL] [Abstract][Full Text] [Related]
16. Variation in the time to treatment for stage III and IV non-small cell lung cancer patients for hospitals in the Netherlands.
van de Ven M; Retèl VP; Koffijberg H; van Harten WH; IJzerman MJ
Lung Cancer; 2019 Aug; 134():34-41. PubMed ID: 31319992
[TBL] [Abstract][Full Text] [Related]
17. Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.
Zhang JT; Li Y; Yan LX; Zhu ZF; Dong XR; Chu Q; Wu L; Zhang HM; Xu CW; Lin G; Yu ZY; Hu J; Zhu B; Wang HJ; Yang F; Song ZB; Han ZB; Li MX; Lin J; Wu YL; Wang JL; Zhong WZ
Lung Cancer; 2020 Jan; 139():118-123. PubMed ID: 31775086
[TBL] [Abstract][Full Text] [Related]
18. The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases.
Thunnissen E; Borczuk AC; Flieder DB; Witte B; Beasley MB; Chung JH; Dacic S; Lantuejoul S; Russell PA; den Bakker M; Botling J; Brambilla E; de Cuba E; Geisinger KR; Hiroshima K; Marchevsky AM; Minami Y; Moreira A; Nicholson AG; Yoshida A; Tsao MS; Warth A; Duhig E; Chen G; Matsuno Y; Travis WD; Butnor K; Cooper W; Mino-Kenudson M; Motoi N; Poleri C; Pelosi G; Kerr K; Aisner SC; Ishikawa Y; Buettner RH; Keino N; Yatabe Y; Noguchi M
J Thorac Oncol; 2017 Feb; 12(2):334-346. PubMed ID: 27998793
[TBL] [Abstract][Full Text] [Related]
19. Stathmin-1 Is a Useful Diagnostic Marker for High-Grade Lung Neuroendocrine Tumors.
Shimizu K; Goto Y; Kawabata-Iwakawa R; Ohtaki Y; Nakazawa S; Yokobori T; Obayashi K; Kawatani N; Yajima T; Kaira K; Mogi A; Hirato J; Nishiyama M; Shirabe K
Ann Thorac Surg; 2019 Jul; 108(1):235-243. PubMed ID: 30910656
[TBL] [Abstract][Full Text] [Related]
20. Impact of rapid investigation clinic on timeliness of lung cancer diagnosis and treatment.
Ezer N; Navasakulpong A; Schwartzman K; Ofiara L; Gonzalez AV
BMC Pulm Med; 2017 Dec; 17(1):178. PubMed ID: 29216855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
